• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » ev3 pays off big for Covidien

ev3 pays off big for Covidien

April 21, 2011 By MassDevice staff

Covidien

The flurry of moves Covidien plc (NYSE:COV) made in 2010 are starting to pay off for the Mansfield, Mass.-based medical products conglomerate.

New business from its $2.6 billion ev3 acquisition helped Covidien double its vascular unit’s sales during the three months ended March 25, posting revenues of $333 million, up 103 percent over the same period last year. And Covidien saw strong increases in sales of energy devices from the $250 million Somanetics buyout it consummated last July. That division reported a 17 percent increase over Q2 2010.

The uptick helped sales of Covidien’s largest segment, its medical device unit, jump 16 percent to $1.88 billion, compared to the $1.62 billion during the same period last year. Domestic sales were particularly strong, jumping 25 percent during the quarter.

The increases jibe with estimates from CFO Charles Dockendorff last fall, who said the device unit would see an overall 10 percent to 13 percent uptick from the shopping spree. Covidien officials said the company will continue to look for tuck-in acquisitions to fill out its device unit over the coming years.

“The growth of the device franchise is a key driver for Covidien,” incoming CEO Jose Almeida told investors during an earnings call this morning. “We’re going to do it both organically and inorganically,” he said.

Almeida, the former medical device chief who was tapped to replace the retiring Richard Meelia in the corner office in Mansfield, said any new buyouts would be aimed at fleshing out its current product portfolio rather than exploring new platforms.

Covidien’s overall business, including pharmaceutical and medical supplies, posted net income of $455 million on $2.8 billion in sales, a 16 percent increase from a $413 million profit on $2.55 billion in revenues for the same period last year.

Covidien increased its 2011 sales guidance, from 6 percent to 9 percent to 8 percent to 11 percent (including foreign exchange rates). COV shares were up 2 percent through midday trading, to $54.85.

Filed Under: MassDevice Earnings Roundup, Mergers & Acquisitions, News Well, Vascular, Wall Street Beat Tagged With: Covidien, ev3 Inc., Q1, Somanetics Corp.

More recent news

  • Imperative Care has positive stroke treatment study results
  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • Intuitive demonstrates remote telesurgery capabilities with da Vinci 5
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • CVRx announces Medicare win for Barostim therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy